DAVID M. STACK - 24 Mar 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: CEO and Chairman, Director
Signature: /s/ Kristen Williams, Attorney-in-Fact
Issuer symbol: PCRX
Transactions as of: 24 Mar 2021
Net transactions value: -$2,151,873
Form type: 4
Filing time: 13 May 2021, 18:01:59 UTC
Next filing: 07 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Gift	$0	-1,080	-1.1%	$0.000000	97,273	24 Mar 2021	By Three Colleens Investment, LLC	F1
transaction	PCRX	Common Stock	Options Exercise	$229,712	+21,250	+28%	$10.81	97,311	11 May 2021	Direct	F2
transaction	PCRX	Common Stock	Sale	$809,468	-13,318	-14%	$60.78	83,993	11 May 2021	Direct	F2, F3
transaction	PCRX	Common Stock	Sale	$485,359	-7,932	-9.4%	$61.19	76,061	11 May 2021	Direct	F2, F4
transaction	PCRX	Common Stock	Options Exercise	$229,712	+21,250	+28%	$10.81	97,311	12 May 2021	Direct	F2
transaction	PCRX	Common Stock	Sale	$180,457	-2,970	-3.1%	$60.76	94,341	12 May 2021	Direct	F2, F5
transaction	PCRX	Common Stock	Sale	$910,652	-14,669	-16%	$62.08	79,672	12 May 2021	Direct	F2, F6
transaction	PCRX	Common Stock	Sale	$225,363	-3,611	-4.5%	$62.41	76,061	12 May 2021	Direct	F2, F7
holding	PCRX	Common Stock						18,596	24 Mar 2021	By Stack Schroon Mohawk FLP	F1
holding	PCRX	Common Stock						315	24 Mar 2021	By LCK Investment LLC	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCRX	Stock Option (Right to Buy)	Options Exercise	$0	-21,250	-16%	$0.000000	109,920	11 May 2021	Common Stock	21,250	$10.81	Direct	F8
transaction	PCRX	Stock Option (Right to Buy)	Options Exercise	$0	-21,250	-19%	$0.000000	88,670	12 May 2021	Common Stock	21,250	$10.81	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
F2	The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.995, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 7.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.68, inclusive.
F5	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.33 to $61.31, inclusive.
F6	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.355 to $62.35, inclusive.
F7	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.355 to $62.595, inclusive.
F8	The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.